Since IL7R signaling exerts its pro-tumor effects not only by promoting tumor cell proliferation and invasion but also by driving the polarization of immunosuppressive TAMs, combining IL7R inhibition with strategies that reprogram TAMs may enhance therapeutic efficacy. This evidence concerns the gene IL7R and neoplasm.